KPJ HEALTHCARE BHD
KLSE (MYR): KPJ (5878)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
2.29
Today's Change
+0.05 (2.23%)
Day's Change
2.23 - 2.32
Trading Volume
8,593,900
Financial
Market Cap
Market Cap
10,366 Million
NOSH
4,527 Million
Latest Quarter
Latest Quarter
30-Jun-2024 [#2]
Announcement Date
28-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
28-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
6.27% | 61.62%
T4Q Result
Revenue | NP to SH
3,675,422.000 | 310,975.000
RPS | P/RPS
81.20 Cent | 2.82
EPS | P/E | EY
6.87 Cent | 33.33 | 3.00%
DPS | DY | Payout %
3.95 Cent | 1.72% | 57.52%
NAPS | P/NAPS
0.54 | 4.24
QoQ | YoY
10.26% | 38.08%
NP Margin | ROE
9.35% | 12.72%
F.Y. | Ann. Date
30-Jun-2024 | 28-Aug-2024
Latest Audited Result
Latest Audited Result
31-Dec-2023
Announcement Date
01-May-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
01-May-2025
Est. Ann. Due Date
29-Jun-2025
Annual (Unaudited)
Revenue | NP to SH
3,418,701.000 | 263,408.000
RPS | P/RPS
75.52 Cent | 3.03
EPS | P/E | EY
5.82 Cent | 39.35 | 2.54%
DPS | DY | Payout %
3.23 Cent | 1.41% | 55.46%
NAPS | P/NAPS
0.51 | 4.48
YoY
53.15%
NP Margin | ROE
7.91% | 11.40%
F.Y. | Ann. Date
31-Dec-2023 | 16-Feb-2024
Annualized Result
Revenue | NP to SH
3,677,148.000 | 294,548.000
RPS | P/RPS
81.23 Cent | 2.82
EPS | P/E | EY
6.51 Cent | 35.19 | 2.84%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
3.14% | 49.0%
NP Margin | ROE
9.75% | 12.05%
F.Y. | Ann. Date
30-Jun-2024 | 28-Aug-2024
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Dividend | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | 3.34% | 2.97% | ||
| Average Net Profit Margin | 9.36% | 8.44% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
| Total Positive Profit Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Profit Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Continuous Quarters Of Adjusted EPS Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Total Dividend Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Dividend Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Continuous Quarters Of Adjusted Dps Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Average ROE | 7.82% | 11.57% | ||
| Average Net Profit Margin | 5.57% | 5.51% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 3,675,422 | 3,677,148 | 3,418,701 | 2,988,333 | 2,993,603 |
| NP to SH | 310,975 | 294,548 | 263,408 | 158,251 | 161,648 |
| Dividend | 178,867 | 174,572 | 146,093 | 85,045 | 78,661 |
| Adjusted EPS | 6.87 | 6.51 | 5.82 | 3.50 | 3.57 |
| Adjusted DPS | 3.95 | 3.86 | 3.23 | 1.88 | 1.74 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | 2.48% | 16.39% | 12.90% | 1.27% | 7.98% |
| NP to Owner | 6.27% | 61.62% | 49.00% | -2.40% | 13.21% |
| Dividend | 0.00% | 53.96% | 60.12% | -2.40% | 16.12% |
| Adjusted EPS | 6.27% | 61.62% | 49.00% | -2.40% | 13.21% |
| Adjusted DPS | 0.00% | 53.96% | 60.12% | -2.40% | 16.12% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.51% | 22.78% | 22.99% | 7.56% | 22.83% | 23.05% | 17.05% | 14.20% | 14.40% |
| NP to Owner | 18.06% | 92.38% | 96.51% | 11.82% | 82.21% | 86.13% | 53.15% | 62.95% | 66.45% |
| Dividend | 22.43% | 127.39% | 110.32% | 19.49% | 121.93% | 105.27% | 68.26% | 85.73% | 71.78% |
| Adjusted EPS | 18.06% | 92.38% | 96.51% | 11.82% | 82.21% | 86.13% | 53.15% | 62.95% | 66.45% |
| Adjusted DPS | 22.43% | 127.39% | 110.32% | 19.49% | 121.93% | 105.27% | 68.26% | 85.73% | 71.78% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
4 people like this. Showing 50 of 1,938 comments
JERUNG sudah habis jual - EPF /KWAP.....bila oraang mau stop jual ? mau beli ooh
2024-03-20 15:46
If don't know how to hold then just sell. Free yourself from the stress.
2024-03-27 12:42
Are you looking at its technical chart, Markv572421? It isn't gg and setuuupiid
2024-04-05 11:24
KPJ to the moon. Gov hospital lack of manpower, those contract doctors moving to Private. 2030 the demand will be higher due to Malaysia aging population
2024-04-05 18:10
KPJ expected to further trend upwards in a secular-bull environment
2024-04-24 21:17
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥
KPJ 20.4.2024
BUSINESS PERFORMANCE
Fiscal year is January-December. All values MYR Millions. 2023
INCOME STATEMENT
SALES/REVENUES 3,419.00
GROSS INCOME 1,432.00
NET INCOME 281.00
NOSH (DILUTED) 4,361.00
-
CASH FLOW STATEMENT -
FUNDS FROM OPERATIONS 619.55
NOCF 607.85
CAPEX -240.50
FREE CASH FLOW 370.35
DIVIDENDS 146.20
-
BALANCE SHEET -
Fiscal year is January-December. All values MYR Millions. 2023
RETAINED EARNINGS 1,390.00
TOTAL EQUITY (Book Value) 2,528.00
TOTAL ASSET 7,246.00
-
MANAGEMENT PERFORMANCE -
Fiscal year is January-December. All values MYR Millions. 2023
GROSS PROFIT MARGIN 41.88%
NET PROFIT MARGIN 8.2%
ASSET TURNOVER 0.49
FINANCIAL LEVERAGE 2.97
ROA 4.0%
ROE 11.9%
DPO RATIO 0.52
-
VALUATION -
FISCAL YEAR ENDING 2023
PRICE 2.000
MARKET CAP 8,722.00
-
NAPS 0.58
EPS 0.06
P/B 3.45
P/E 31.04
EARNINGS YIELD 3.22%
FCF YIELD 4.25%
DIVIDEND YIELD 1.68%
2024-04-24 23:52
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥
Fiscal year is January-December. All values MYR Millions. 2023
CASH AND EQUIVALENT 785
ST DEBT & CURRENT PORTION OF LT DEBT 587
LT DEBT 3,235
TOTAL DEBT 3822
NET CASH (DEBT) -3037
EBIT 452
Interest Expense 205
2024-04-24 23:57
KPJ Healthcare Berhad (“KPJ Healthcare” or the “Group”) through its premier educational institution, KPJ Healthcare University ("KPJU"), entered into a Memorandum of Understanding (“MoU”) with Trusx Malaysia Sdn Bhd (“Trustr”), a global digital health organisation, in a transformative step towards revolutionising healthcare.
https://www.malaysiakini.com/announcement/703938
2024-04-29 17:32
wow after months I've commented this (Dec 23), finally it went B.O all the way up to rm2
congrats to investor!
2024-05-26 16:57
govt will soon shortlist pte hospitals for healthcare outsourcing from Govt hospitals. The outsourcing covers cardiothoracic surgery, medical imaging, cardiology services & nephrology.
2024-06-15 15:45
Dow Jones
Dow Jones Industrial Average
40,247.10
-489.86
1.20%
Nasdaq
NASDAQ Composite
16,993.71
-32.17
0.18%
2 months ago
KPJ: Breakout Stock with Crossover and Uptrend Pattern
https://klse.i3investor.com/web/blog/detail/bestStocks/2024-09-18-story-h469188539-KPJ_Breakout_Stock_with_Crossover_and_Uptrend_Pattern
2 months ago
KPJ Healthcare (KPJ MK) – on track to achieve a 20% year-on-year growth in medical tourism revenue for 2024, with the Malaysia Healthcare Travel Council targeting a revenue of RM2.4 billion for the year. Thank you
https://www.minichart.com.sg/2024/10/08/kpj-healthcare-kpj-mk-on-track-to-achieve-a-20-year-on-year-growth-in-medical-tourism-revenue-for-2024-with-the-malaysia-healthcare-travel-council-targeting-a-revenue-of-rm2-4-billion-for/
1 month ago
Malaysia will bring in thousands injured middle east war patients for free treatment, fully funded by new tax in 2025 budget.
1 month ago
Upbeat outlook for KPJ on sound strategies. Buy buy buy
https://www.thestar.com.my/business/business-news/2024/10/17/upbeat-outlook-for-kpj-on-sound-strategies
1 month ago
Breaking new levels, monitor. Could it be late response to this: https://bernama.com/en/general/news.php?id=2356923
2 weeks ago
Charting new highs - TP 2.35 - 2.50. Buyers in control, all indicators point to increasing bullishness in anticipation of good QR yield
1 week ago
Two weeks to QR release. Buyers still in control despite Thursday profit-taking. Matter of time before breaking 2.30 for next high
6 days ago
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-21 16:20:00
EMA 5
5 Mins
SELL
2024-11-21 14:35:00
TURTLE SYSTEM 20
5 Mins
SELL
2024-11-21 14:35:00
TURTLE SYSTEM 55
5 Mins
SELL
2024-11-21 12:15:00
ADX
5 Mins
BUY
2024-11-21 12:15:00
TURTLE SYSTEM 20
5 Mins
BUY
Apps
Top Articles
1
2
3
Good Articles to Share
4
Koon Yew Yin's Blog
Why all plantation companies will continue to report more profit - Koon Yew Yin
5
6
save malaysia!
7
AmInvest Research Reports
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Markv572421
hahahaha....
2024-03-19 16:22